| pubmed-article:17099033 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17099033 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17099033 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:17099033 | lifeskim:mentions | umls-concept:C0231921 | lld:lifeskim |
| pubmed-article:17099033 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:17099033 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:17099033 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17099033 | pubmed:dateCreated | 2006-11-13 | lld:pubmed |
| pubmed-article:17099033 | pubmed:abstractText | Chronic heart failure (CHF) is associated with neurohumoral activation and decrements in pulmonary function (PF). The beta2-adrenergic receptor (ADRB2) modulates airway smooth muscle tone and influences lung fluid clearance. Common polymorphisms of the ADRB2 are associated with differences in ADRB2 function and therefore could differentially influence PF in patients with CHF. | lld:pubmed |
| pubmed-article:17099033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17099033 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17099033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17099033 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17099033 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17099033 | pubmed:issn | 0012-3692 | lld:pubmed |
| pubmed-article:17099033 | pubmed:author | pubmed-author:TurnerStephen... | lld:pubmed |
| pubmed-article:17099033 | pubmed:author | pubmed-author:JohnsonBruce... | lld:pubmed |
| pubmed-article:17099033 | pubmed:author | pubmed-author:SnyderEric... | lld:pubmed |
| pubmed-article:17099033 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17099033 | pubmed:volume | 130 | lld:pubmed |
| pubmed-article:17099033 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17099033 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17099033 | pubmed:pagination | 1527-34 | lld:pubmed |
| pubmed-article:17099033 | pubmed:dateRevised | 2007-12-3 | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:meshHeading | pubmed-meshheading:17099033... | lld:pubmed |
| pubmed-article:17099033 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17099033 | pubmed:articleTitle | Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure. | lld:pubmed |
| pubmed-article:17099033 | pubmed:affiliation | Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:17099033 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17099033 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17099033 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:154 | entrezgene:pubmed | pubmed-article:17099033 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17099033 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17099033 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17099033 | lld:pubmed |
